Fisher & Paykel Healthcare Corporation Limited
FPH
주식 순위
#1289
Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes... Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes in the development, manufacturing, and marketing of a wide array of medical device products and systems. These solutions are primarily utilized for acute and chronic respiratory care, during surgical procedures, and in the treatment of obstructive sleep apnea (OSA) within both hospital and home environments. Key offerings include the Airvo 2, a humidified nasal high flow system; Optiflow, for nasal high flow therapy; and the F&P 850 System, which facilitates noninvasive and invasive ventilation. The company also provides a comprehensive range of infant respiratory products, encompassing devices for resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Its extensive hospital product portfolio features humidification equipment, breathing circuits, chambers, various masks, nasal cannulas, surgical components, and different interfaces and accessories. For homecare, Fisher & Paykel Healthcare supplies masks, CPAP devices, data management software, humidifiers, and related accessories. Established in 1934, the company is headquartered in Auckland, New Zealand.
주가
$28.21
시가총액
$16.57B
변동 (1일)
-4.64%
변동 (1년)
37.41%
국가
NZ
거래 Fisher & Paykel Healthcare Corporation Limited (FPH)
카테고리
Healthcare
Fisher & Paykel Healthcare Corporation Limited (FPH)의 EPS
2026 기준 EPS TTM: 0
Fisher & Paykel Healthcare Corporation Limited의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Fisher & Paykel Healthcare Corporation Limited의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 제공된 날짜에 대한 데이터가 충분하지 않습니다. | ||
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $8.85 | - |
US
|
|
| $6.41 | - |
FR
|
|
| - | - |
JP
|
|
| $3.32 | - |
US
|
|
| - | - |
CH
|
